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SUMMARY
This is the ﬁrst study comparing societal costs of acute illness with Salmonella Typhimurium (ST)
and Salmonella Enteritidis (SE) in the UK. It included the cost and severity of the illness and
explored the impact of each Salmonella serovar on the patients, their families, the NHS, and the
wider economy. The study ascertained conﬁrmed cases of ST and SE between July and November
2008. The mean costs per case were £1282 (ST) and £993 (SE). The indirect costs associated with
the work-time lost by the case, parents, or carers were £409 (ST) and £228 (SE); this diﬀerence
was statistically signiﬁcant. The aggregate cost of ST and SE identiﬁed using laboratory test
results for the UK as a whole was estimated as £6.5 million. Work-time lost and caring activities
are cost categories that are not frequently investigated within the infectious intestinal disease
literature, although they represent an important societal cost.
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INTRODUCTION
Salmonella causes signiﬁcant diarrhoea, vomiting,
nausea, fever, and abdominal pain. It is one of the
most important foodborne pathogens in the devel-
oped world. It levies a considerable burden in terms of
morbidity and mortality [1, 2]. Outbreaks of human
salmonellosis are common in many countries and
infection has been linked to a range of food vehicles
including eggs, chicken, beef, pork, salad vegetables
and dairy products [3, 4]. Some cases are associated
with travel [5].
Salmonella enterica is a zoonosis and diﬀerent
serovars can be carried by livestock raised for food
production. National surveillance shows that the
number of cases of human salmonellosis has declined
since 1997. This decline is mainly attributable to the
reduction in the incidence of illness due to Salmonella
Enteritidis (SE) phage type 4, following the intro-
duction of vaccination against SE in the majority of
ﬂocks in the UK egg industry [6]. In 2008, there were
about 9800 reported cases of human salmonellosis
in the UK. Around 4200 were due to SE and 1800
were associated with Salmonella Typhimurium (ST)
[7]. SE remains most strongly associated with poultry
and poultry products. ST has a wide host range, in-
cluding poultry, cattle, sheep and pigs [8–10]. In the
UK, ST was found in about 14% of slaughter pigs
in a European baseline abattoir survey [11].
Data from the ﬁrst Infectious Intestinal Disease
study in England (IID) [12], which was conducted
in the early 1990s, estimated an annual incidence
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of 3.2 cases/1000 population of Salmonella in the
community and 2.3 cases/1000 persons-year to the
cases that presented to General Practitioners (GPs).
In a recent 10-year period study (1999–2008) in
Cambridge, it was estimated that there was an annual
incidence of 20.06 cases/100 000 persons, indicating
that Salmonella infections are still causing consider-
able morbidity in England [13].
Salmonellosis has a signiﬁcant socioeconomic
impact on the daily activities of cases and carers. It
produces considerable morbidity and although deaths
are not common they do occur especially in vulner-
able people. Families incur expenses and lose time oﬀ
work because of the illness and their caring responsi-
bilities. Society loses productivity and National
Health Service (NHS) resources are used both in pri-
mary care and in hospital services [12, 14].
European Commission Regulations require mem-
ber states to meet targets for reduction of Salmonella
in diﬀerent livestock sectors and each member state
must present plans for approval in order to meet these
reduction targets [15]. Preventive measures in egg
production, for instance, have been shown to be
successful in reducing morbidity and mortality for
salmonellosis [7] and in Denmark, reduction in the
prevalence of Salmonella infection in pigs was associ-
ated with a reduction in human cases [16]. Whether
these measures are cost-eﬀective requires investi-
gation.
The research reported here is one component of a
multidisciplinary project for Salmonella control in
pigs. This paper reports on the costs of Salmonella,
i.e. ST and SE. It includes the cost and severity of the
illness and explores the impact of each type on the
patients, their families, the NHS, primary and sec-
ondary services and the wider economy. This is the
ﬁrst study that compares societal costs of ST and SE
in the UK. A subsequent paper will present the inte-
gration of these results to a quantitative microbial risk
assessment and the cost-eﬀectiveness of interventions
to control Salmonella infection in pigs, examining
the beneﬁts of control represented as avoided cases of
human salmonellosis.
METHODS
Study population, sample size and data collection
This economic study was conducted as part of a
multidisciplinary project which addressed the epi-
demiology of Salmonella infection in pigs and the
risk of human Salmonella attributable to pig meat,
through ﬁeld-based studies. The study consisted of all
laboratory-conﬁrmed cases of human ST notiﬁed
within 2–4 weeks of onset to the Health Protection
Agency (HPA). Cases were identiﬁed through faecal
and blood isolates referred to the HPA Salmonella
Reference Unit (SRU) for serological and phage
typing using the method described by Ward et al. [17].
To place ST in the broader context of the Salmonella
group, we selected a comparable group (of equivalent
age and gender) of SE cases, one for each ST case. The
objective was to enable us to compare the relative
burden of two diﬀerent Salmonella serovars and, in
addition, to provide information about SE that was
not available from other sources. It was not a case-
control study.
The inclusion criteria were as follows: all ages, both
sexes, resident in the UK. Cases were included even if
their ‘stool ’ request form mentioned travel. Cases of
ST and SE from persons in prisons or from those not
able to give informed consent and who had no one to
act on their behalf were not invited to participate.
Cases arising from an outbreak which was known to
be under investigation were not included, to avoid
jeopardizing the outbreak investigation, but details of
the investigation were requested from the investigat-
ing team.
It was not possible to determine, for an economic
study, the dimensions needed for a statistically de-
rived sample, as sparse information was available
about the variation in parameters of notiﬁed cases.
It was proposed that a replacement sample of
200 cases of ST and 200 age- and sex-matched cases
of SE should be recruited into the study.
Ethical approval from the NHS Ethics Committee
and the London School of Hygiene and Tropical
Medicine was gained before the ﬁeldwork took place.
Cases of ST conﬁrmed at the National SRU were
randomly selected each week, which matched (age
and gender) cases of SE. The addresses of all cases
were obtained from the laboratory where the stool
sample was initially tested. A consent letter, ques-
tionnaire, study information sheet describing the
purpose of the study, and a letter from the HPA were
sent by post. Those consenting were asked to com-
plete a questionnaire and return it in the stamped
addressed envelope provided. All responses were
voluntary.
The data collected included: age, gender, house-
hold size, length of disease, severity, impact of the
illness on the activities of daily living, the use of
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healthcare resources, personal medical expenditure,
time oﬀ work, lost income due to the illness, time oﬀ
work and loss of income due to caring for the ill. The
questionnaire also included a self-assessment on the
cases’ health status, using a standard methodology
(SF-16 and Euroqol [18, 19]). Results of this assess-
ment will be reported separately. Parents or carers of
children and carers of inﬁrm patients completed the
questionnaire on their behalf. People with language
diﬃculties were asked to use an interpreter who could
record the patient’s responses to the questionnaire on
their behalf.
Cost methodology
This study presents the estimates of the direct costs
incurred by parents, families and carers of cases and
the direct costs for the use of the NHS by the patients.
The costs of laboratory tests, sample collection and
analysis were not included in the cost analysis. The
frequency of patients’ use of NHS resources was
collected from the questionnaire. All costs were esti-
mated using standard methodology, where the mean
use of resource is multiplied by the unit cost of the
referred resource to produce the estimated direct
mean cost incurred by the families and the estimated
direct mean cost of patients’ use of the NHS resources
[20, 21].
Direct costs incurred by parents, families and
carers were estimated from information on out-
of-pocket expenditures. Costs of drugs were assumed
to be those informed by the case as direct expendi-
ture for non-prescribed drugs. For prescribed drugs,
we considered the prescription charge incurred
by the patient, when the family was not eligible for
free medicines. No case said they received free
medicines. The NHS part of the cost of prescribed
drugs was estimated as £18 per case charged, in
accordance with 2008 NHS Department of Health
ﬁgures [22]. This cost has been inputted to the NHS
costs accordingly. That deals with the transfer
payments.
Cases’ cost per call to their GPs was estimated as
the average duration of each call to GPs (estimated
as 8 minutes and 48 seconds [23] multiplied by the
cost per minute (£0.52 [24]). Thus the cost per call was
estimated to be £0.44. Parental (and carer) costs of
days/time of lost work and income were estimated
using the Annual Survey of Hours and Earnings
(ASHE) from the UK National Statistics [25] and
the current occupation, as informed by the case. This
cost was assumed to be an indirect cost for society
and corresponded to the social cost due to one case
(parent or carer) being absent from work due to
illness.
Costs of GP surgery and home visits, nurse visits,
out-of-hours clinic, accident and emergency depart-
ment (A&E) visits, in-patient infectious disease, in-
tensive therapy unit (ITU), isolation ward (IW), and
ambulance to the hospital were estimated based on
NHS Reference Costs 2007/2008 data [26]. The unit
cost of an in-patient infectious disease was assumed
to be the average cost of the low-high infectious
status, in accordance with the NHS deﬁnition [26].
ITU, IW and ambulance unit costs were also assumed
to be an average cost from the general categories
presented by the NHS study. Cost of GP phone call to
patient was also assumed to be £0.44 per call (see
above). NHS direct cost was assumed to be £25.53,
based on 2007/2008 ﬁgures [23]. Estimation of the
average cost for the nurse visits was only available for
the period 2004/2005 [27]. Therefore, we have applied
a consumer price index to this estimate to bring prices
to 2008 levels and have a rough approximation for
this cost, i.e. Retail Price Index for group 06 – Health
(personal goods and services – health-related items)
[28]. All costs are presented in 2007/2008 sterling (£)
values.
Analysis
All analysis was undertaken using SPSS version
14.0 [29], where means and proportions were cal-
culated. To test socioeconomic and demographic,
and costs and use of resources, we used a Student’s
t test for independent-samples, which compares the
means of a normally distributed random variable
or the Mann–Whitney U test, if the distribution
was non-normal. The x2 test was used to compare
proportions. Only the P values of the tests are
presented at a signiﬁcance level of 95% (i.e. P=
0.05).
Because we have no statistical distribution of
economic variables to test the robustness of esti-
mates, we use sensitivity analysis, which indicates
how the estimates would react to percentage changes
in the value of the parameters of the model. The
analysis was applied to the NHS cost categories.
We assumed that the vectors were increased or de-
creased by 10%, 20% and 50% to indicate the likely
boundaries of costs, provided by a 95% conﬁdence
interval [14].
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RESULTS
Response rate
Between July and November 2008, 2869 reports of
ST and SE were generated by the SRU. Of these re-
ports 1254 were followed up to acquire postal address
details, of which 724 had full study packs (consent
letter, questionnaire, study information sheet and a
letter from the HPA) posted. Consent was given by
353 (49%) and 296 (84%) returned the questionnaire.
Reasons for non-consent were not provided. From
the questionnaires returned, 35 (12%) were either in-
complete, with no information at all, or with missing
pages. The ﬁnal useable response was 261 (36%
of 724).
Characteristics of the cases
In the ST group, 59% were women (mean age
38 years), and about 41% of the cases were employed;
whereas in the SE group 47% were female (mean age
35 years), and 37% were working. For both groups,
there was an average of three people living in the
household.
Considering these general characteristics, the
groups did not signiﬁcantly diﬀer from each other.
However, when we stratiﬁed by age group, costs and
health outcome in children aged <5 years were sig-
niﬁcantly diﬀerent between ST and SE.
Characteristics of the illness and impact on activities
of daily living
Diarrhoea, abdominal pain, fever, and headache
were the most frequent symptoms associated with
ST and SE, although the frequency of vomiting and
joint pain was also relatively high. The mean number
of days with each symptom was, for ST and SE, re-
spectively: diarrhoea, 8.5 and 9 days; abdominal
pain, 6.5 and 7 days; fever, 4 days for both and
headache 3 days for both.
The severity of the disease was mostly measured
by the ability of the cases to re-start their normal
activities. In this study, in spite of diarrhoea symp-
toms having a mean duration of 8.5 and 9 days for
ST and SE, respectively, the reported length of illness
from the beginning until the individual was able to
carry out daily activities was, on average, 13.5 days
and 12 days, respectively. Cases were away from paid
work for 5 days and 3 days, from nursery, school or
college for 1 and 1.5 day, and from planned leisure
and/or social activities for 4 days and 3 days for ST
and SE, respectively. About 21% of ST cases and
22% of SE cases were still suﬀering from the symp-
toms at the time of the survey (average of 48 and
49 days for ST and SE, respectively).
Caring activities were observed in diﬀerent con-
texts. Cases needed ‘someone else to take their place
as a carer ’ (14% and 13%); ‘someone to take care of
them’ (69% and 59%); someone ‘to visit the GP
surgery’ (51% and 15%); help to visit ‘out-of-hours
clinic ’ (12% and 10%); help with ‘A&E visits ’ (22%
and 10%); someone to ‘accompany them to hospital ’
(13% and 9.5%); and someone to ‘stay with them
in hospital ’ (9%), for both ST and SE, respectively.
Carers were mostly relatives and friends. For the
group who needed someone to take care of them (the
major carer group), 10.5% and 15% of the carers
took time oﬀ work, with an average time of 1.1 and
1.3 days oﬀ work. We did not ﬁnd a statistically sig-
niﬁcant diﬀerence between the ST and SE groups.
Direct out-of-pocket expenses to cases
Costs reﬂected the severity of the disease. The mean
direct out-of-pocket cost (for all age groups) was £55
for ST and £58 for SE, where transport and other
costs had a higher proportion of the total (Table 1).
Only the ‘replacement of clothing cost ’ was signiﬁ-
cantly diﬀerent between the two groups. However,
when we stratiﬁed by age group, the ST and SE
groups presented diﬀerences of costs : for children
aged<5 years, transport cost (P=0.006), extra laun-
dry (P=0.019), special food (P=0.035), prescribed
medicines (P=0.033), and toys/books (P=0.026)
were statistically signiﬁcant. The average direct costs
within these groups were £78 for ST and £40 for SE
(P=0.017); for adults aged >20 years, the only sig-
niﬁcant cost that accounted for the diﬀerence between
ST and SE groups was the special foods cost (P=
0.046) which was higher for ST adults aged>20 years
(£64). The overall Salmonella direct cost for the cases
was £56 (ST and SE).
The societal indirect cost associated with the loss of
work-time by the case, parents of ill children, or carer
was £409 for ST and £228 for SE, and this diﬀer-
ence was statistically signiﬁcant between the groups
(Table 2). This reﬂected the distribution of cases and
employment status of the cases, parents and carers.
Use and costs of resources to the NHS
The estimated average NHS cost per patient, was
£818 and £707, for ST and SE, respectively, where the
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main expenditures were for hospitalization (£449 and
£319), ITU (£116 and £217), and isolation ward care
(£118 and £74). Patients who were admitted to hos-
pital had spent, on average, 1.2 days (those with ST)
and 1 day (those with SE) there ; there were 20 (16%)
and 24 (17%) patients hospitalized, for ST and SE,
respectively. Three patients in the ST group and one
patient in the SE group were admitted to the ITU;
whereas 15 and 13 patients with ST and SE were
admitted to the IW (Table 3).
Visits to the GP were common in cases : 97 patients
were seen by a GP in the ST group and 115 in the SE
group, with an average of 1.5 and 1.8 days of visits,
respectively. The mean cost of a GP surgery visit was
£32 and £37 for ST and SE, respectively.
In general, patients in each group were similar to
each other, except for GP home visits (P=0.035), out-
of-hours clinics (P=0.004), A&E visits (P=0.000)
and IW care (P=0.045).
When stratiﬁed by age we observed that, in our
sample, the use of ITU and ambulance were not re-
ported by children aged<5 years. The main costs for
this group were for hospitalization (62% and 52%),
IW (17% and 13.5%), and GP surgery visits (7% and
14%) for ST and SE, respectively. ST and SE groups
were statistically diﬀerent in this age category for
Table 1. Direct out-of-pocket expenses to cases by age group (£ sterling, 2008 prices)
ST (N=124) SE (N=137) P value
Children<5 years : mean (range ; S.D.) n=12 n=25
Transport (including parking) 38.28 (0–400; 114.23) 3.28 (0–20; 6.41) 0.006
Extra laundry 2.5 (0–15; 5.00) 1.12 (0–10; 2.52) 0.019
Replacement of clothing 3.75 (0–20; 7.72) 2.80 (0–20; 5.60) 0.344
Nappies 10.25 (0–40; 12.56) 9.95 (0.35 ; 9.97) 0.496
Special foods 0.58 (0–7; 2.02) 2.80 (0–30; 6.93) 0.035
Medicines (bought) 2.58 (0–20; 5.76) 2.56 (0–20; 4.80) 0.963
Prescribed medicines (charges) 0 3.60 (0.10–45; 11.77) 0.033
Toys/books, etc. 3.58 (0–43; 12.41) 0.92 (0–10; 2.64) 0.026
Other (disinfectants, phone calls, etc.) 16.67 (0–200; 57.73) 13.12 (0–150; 34.76) 0.490
Average direct cost (children<5 years)* 78.20 (0–440; 129.84) 40.15 (0–180; 44.77) 0.017
Adults>20 years : mean (range ; S.D.) n=84 n=84
Transport (including parking) 7.31 (0–104; 17.22) 5.73 (0–210; 25.35) 0.759
Extra laundry 2.33 (0–40; 6.80) 1.94 (0–20; 4.63) 0.444
Replacement of clothing 1.68 (0–75; 9.30) 3.75 (0–200; 22.21) 0.144
Nappies 1.18 (0–40; 5.64) 0.81 (0–40; 4.87) 0.370
Special foods 4.57 (0–60; 11.37) 2.20 (0–60; 8.86) 0.046
Medicines (bought) 4.81 (0–50; 9.20) 3.64 (0–30; 6.39) 0.077
Prescribed medicines (charges) 3.06 (1.0–40; 6.97) 2.62 (0.10–25; 5.80) 0.431
Toys/books, etc. 0.30 (0–10; 1.62) 0.31 (0–10; 1.46) 0.944
Other (disinfectants, phone calls, etc.) 38.72 (0–1000; 169.34) 33.01 (0–1600; 184.02) 0.729
Average direct cost (adults>20 years)* 63.94 (0–1000; 198.14) 53.94 (0–1600; 191.80) 0.775
All age groups: mean (range ; S.D.) n=124 n=137
Transport (including parking) 10.04 (0–400; 39.25) 7.50 (0–300; 33.21) 0.634
Extra laundry 2.47 (0–40; 6.85) 1.86 (0–20; 4.46) 0.204
Replacement of clothing 1.68 (0–75; 8.14) 3.85 (0–200; 19.48) 0.039
Nappies 1.99 (0–40; 6.71) 2.49 (0–40; 6.83) 0.329
Special foods 3.79 (0–60; 9.96) 2.26 (0–60; 8.03) 0.057
Medicines (bought) 3.94 (0–50; 8.12) 3.23 (0–30; 5.92) 0.118
Prescribed medicines (charges) 2.09 (1.0–40; 5.90) 2.35 (0.10–45; 6.86) 0.350
Toys/books, etc. 0.83 (0–43; 4.43) 1.12 (0–50; 5.23) 0.379
Other (disinfectants, phone calls, etc.) 28.08 (0–1000; 141.11) 32.86 (0–1600; 168.59) 0.672
Average family direct costs* 54.93 (0–1350; 169.40) 57.52 (0–1644; 197.33) 0.782
Overall Salmonella cost (ST+SE=261 cases) 56.43 (0–1644; 183.53)
* This is the sum of all direct cost items.
P value (0.05) of the t test for the diﬀerence in means for independent-samples or the Mann–WhitneyU test if the distribution
was non-normal.
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A&E visits, hospitalizations, IW costs, and prescribed
medicine costs.
For the >20 years group, hospitalization (53%
and 40.5%), ITU (19% and 40.5%) and IW (13%
and 7%) accounted for the main NHS costs for ST
and SE, respectively. A&E visits and IW explained the
diﬀerences between the ST and SE groups.
Sensitivity analysis
Table 4 shows the sensitivity analysis. NHS costs were
robust estimates lying within the 10% sensitivity
band, which means that variations of 10% (to more
or less) of the best estimated values were still lying
within the conﬁdence interval. The limits for the 95%
conﬁdence interval were large for most of the esti-
mated costs, especially for hospitalization, ITU and
IW (categories that contribute most to the NHS total
mean cost), GP home visit, out-of-hours clinic, and
ambulance, and it reﬂected the skewed distribution
of illness.
Mean and total costs to society
Costs of use of NHS resources were proportionally
the highest social cost related to ST and SE: 64% and
71%, respectively. Families faced 4% and 6% of the
total social cost ; and the proportions of the indirect
cost with work-time lost were 32% and 23% for ST
and SE, respectively. The mean social costs per case
of salmonellosis were £1282 (ST) and £993 (SE).
Considering 1829 ST cases and 4190 SE cases were
reported in 2008 that shared the same case deﬁnition
as the cases reported [30], the total cost for the UK
economy for these two bacteria was more than
£6.5 million. Of this, the NHS cost would have ap-
proximated to £4.5 million (68.5% of the total). The
share of the burden to cases and carers was estimated
as £2 million (31.5%) (Table 5).
DISCUSSION
This is the ﬁrst study where the societal costs were
compared for two diﬀerent Salmonella serovars,
showing how this illness can aﬀect the families and the
NHS.
Salmonellosis due to ST and SE had a substantial
social cost : an average of £1282 and £993 per case,
respectively, and a total cost for the UK wider econ-
omy of more than £6.5 million. This estimate does not
include the community cases that either did not see
Table 2. Work time lost, total mean cost (£ sterling, 2008 prices)
Value of work
time lost
(categories)
Unit
cost*
ST (N=124) SE (N=137)
P value
Time
lost (days)
n (mean; S.D.)
Total
mean cost
(£ 2008)
Time
lost (days)
n (mean; S.D.)
Total
mean cost
(£ 2008)
I 141.84 0 0 5 (1.60; 2.30) 226.94
II 154.24 17 (10.29 ; 14.68) 1587.13 12 (4.92; 6.93) 758.86
III 110.72 6 (8.17 ; 3.60) 904.58 6 (5.00; 8.15) 553.60
IV 73.20 7 (9.86 ; 9.19) 721.75 10 (6.20; 6.14) 453.84
V 82.08 0 0 1 (28.00; 0) 2298.24
VI 62.80 8 (7.5 ; 7.27) 471.00 5 (7.00; 5.83) 439.60
VII 51.12 11 (11.18 ; 11.09) 571.52 6 (0.17; 0.41) 8.69
VIII 70.88 0 0 1 (3.00; 0) 212.64
IX 52.72 2 (11.50 ; 19.09) 606.28 6 (15.17; 12.80) 799.76
Overall 84.24 124 (4.86; 9.43) 409.41 137 (2.71; 6.31) 228.29 0.003
The Annual Survey of Hours and Earnings (ASHE), United Kingdom National Statistics (http://www.statistics.gov.uk/
StatBase/Product.asp?vlnk=15187).
n, Number of respondents ; mean: all respondents including zeros.
Categories : I, Managers and senior ; II, professional occupations ; III, associate professional and technical occupations ;
IV, administrative and secretarial occupations ; V, skilled trades occupation; VI, personal services ; VII, sales and customer
services occupation; VIII, process, plant and machine operations ; IX, elementary occupations.
* Unit cost per day by work category ; calculated as median hourly paid (excluding overtime) multiplied by 8 hours.
P value (0.05) of the t test for the diﬀerence in means for independent-samples or the Mann–WhitneyU test if the distribution
was non-normal.
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a GP or saw a GP but were not asked to bring a stool
sample for examination. As demonstrated in the IID
study, the average cost per case is lower if the com-
munity cases who did not seek medical advice are
included. The diﬀerence of the estimated costs be-
tween the two serovars is explained largely by the
absence of NHS cost in the community group and by
the reduced severity of illness and less time oﬀ work.
Cases with ST would spend more time away from
paid work and would need more time from someone
else to take care of them, to accompany them to visit
the doctors and/or to be with them at the hospital.
Cases with ST would also spend more NHS resources
compared to the SE group. However, these results
should be interpreted with caution due to many in-
herent biases that might inﬂuence the estimated aver-
age costs and the diﬀerence between them.
The study may have lacked power to detect diﬀer-
ences in some categories due to the limited sample
size, which was composed of cases identiﬁed in the
laboratory that returned the questionnaire, not from
a required sample size for hypothesis tests. This pro-
cedure can lead to bias of selection where only
individuals from a better economic standard and
educational level may have been included, aﬀecting
the estimated costs and the diﬀerences between them
[31]. This may have been reﬂected in the work cat-
egories used as the basis to calculate the work-time
lost by cases, on the selection of patients with under-
lying medical conditions associated with ST and SE,
which may have aﬀected their hospitalization time
and time at the ITUs or IWs. The selection bias may
also have been associated with the many unique
genotypes represented in both the ST and SE cat-
egories. No further investigations were conducted to
overcome these possible sources of bias.
Whereas the diﬀerence between the estimated
work-time lost by cases may have been aﬀected by
selection bias, our results clearly suggest that the
health burden of salmonellosis in terms of absence
from work is considerable : ST cases lost, on average,
4.86 days and SE cases 2.71 days.
Work-time lost by cases, parents or carers and
caring activities are cost categories that are not fre-
quently investigated within the infectious intestinal
disease literature, although they represent an import-
ant societal cost, as demonstrated in this study. In
most previous studies attention has been concentrated
on hospitalization and ambulatory costs. In the ﬁrst
IID study conducted in England [12], the overall mean
loss of days of paid employment of salmonellosis
cases, parents or carers was 4.83 days. Speciﬁcally for
SE, this was 3.48 days, with an overall mean cost of
£370 to the case and £71 to the carer (total case and
carer £440); whereas in our study, cases with SE
spent, on average, 2.71 days away from paid work,
costing £228 to society. No societal speciﬁc cost per
ST case was reported by the IID study, probably due
to the small sample size.
There were very large diﬀerences in the NHS costs
estimated by the IID study and our study: the ST
mean cost was estimated as £133 (excluding labora-
tory costs) in the IID study and £818 in our study; for
SE it was £48 and £707, respectively. These diﬀerences
can be explained by the hospitalization costs. In the
IID study, no cases reported admission to the ITU
or IW, while in our study, four cases (three ST and
one SE) said they used ITU resources and 28 cases
(15 ST and 13 SE) used IW resources. These costs
represented 29%and 41%of our total NHS estimated
direct costs. Another substantial cost was for hospital
admission: ST cases reported about 0.36 days spent
at hospital in the IID study, while in our study the
average was 1.24 days; for SE, no cases said they had
spent time at the hospital in the IID investigation,
but in our study cases stated they spent, on average,
0.88 days in hospital. The hospital costs represented
55% and 45% of the total NHS direct cost per
patient with ST and SE, respectively [12].
The fact that the ﬁrst IID study did not report on
admission to ITUs and IWs might be related to the
small sample size that was available for analysis
during that period and, hence, has made it diﬃcult
to capture information from the more serious cases.
It is also possible that some of the seriously ill cases
who were admitted to hospital were lost to the study
sample (J. A. Roberts, personal communication). On
the other hand, the 261 cases investigated by our
study could represent a more severely ill group of
people, for whom laboratory specimens were avail-
able. We did not conduct any medical record in-
vestigations to dissociate Salmonella from any other
medical condition, and then estimate the costs ac-
cordingly. Moreover, this study did not include cases
that were not tested, i.e. those in the community and
those presenting to a GP who were not asked for a
stool examination. Consequently, these ﬁndings may
not be representative of the whole population.
The diﬀerence in NHS costs for the two groups was
statistically signiﬁcant only for GP home visits (P=
0.035), out-of-hours clinics (P=0.004), A&E visits
(P=0.000) and IW care (P=0.045). This suggests
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Table 3. Breakdown of NHS costs per case (£ sterling, 2007/2008 prices)
ST (N=124) SE (N=137)
P valueNHS cost category
NHS reference
price (£) n (mean; S.D.)
Cost per
case (£) n (mean; S.D.)
Cost per
case (£)
Children<5 years, n (mean; S.D.) n=12 n=25
GP surgery visit 21.40 11 (1.92 t ; 1.16) 41.09 (7.4%) 23 (2.04 t ; 1.48) 43.66 (14.2%) 0.594
GP home visit out of hours 93.73 0 0 1 (0.04 t ; 0.20) 3.75 (1.2%) 0.160
Nurse home visit* 56.00 2 (0.25 t ; 0.62) 14.00 (2.5%) 6 (0.40 t ; 0.82) 22.40 (7.3%) 0.288
GP phone call : NHS 0.44 10 (1.92 t ; 1.44) 0.85 (0.2%) 20 (1.96 t ; 1.64) 0.86 (0.3%) 0.850
GP phone call : patient 0.44 4 (0.42 t ; 0.67) 0.18 (0.0%) 15 (1.12 t ; 1.27) 0.49 (0.2%) 0.101
NHS direct 22.50 5 (0.56 t ; 0.53) 12.60 (2.3%) 10 (0.40 t ; 0.50) 9.00 (2.9%) 0.063
Out-of-hours clinic 75.00 1 (0.08 t ; 0.29) 6.00 (1.0%) 2 (0.16 t ; 0.62) 12.00 (3.9%) 0.400
A&E visit 79.00 4 (0.50 t ; 0.90) 39.50 (7.1%) 3 (0.12 t ; 0.33) 9.48 (3.1%) 0.002
In-patient : infectious disease 362.00 4 (0.96 d; 1.74) 347.52 (62.1%) 6 (0.44 d; 0.92) 159.28 (51.7%) 0.038
Intensive therapy unit 1447.00 0 0 0 0 —
Isolation ward 130.00 2 (0.75 d; 1.76) 97.50 (17.4%) 3 (0.32 d; 0.90) 41.60 (13.5%) 0.033
Ambulance (to the hospital) 212.00 0 0 0 0 0.918
Prescribed medicine (charges)# 18.00 0 0 3 (0.52 m; 1.66) 5.76 (1.9%) 0.028
NHS cost children<5 years 559.24 (100%) 308.28 (100%)
Adults>20 years, n (mean; S.D.) n=84 n=84
GP surgery visit 21.4 66 (1.49 t ; 1.33) 31.89 (3.5%) 69 (1.75 t ; 1.63) 37.45 (4.2%) 0.724
GP home visit out of hours 0 11 (0.15 t ; 0.42) 14.06 (1.6%) 10 (0.15 t ; 0.45) 14.06 (1.6%) 0.945
Nurse home visit* 93.73 24 (0.40 t ; 0.89) 22.40 (2.5%) 18 (0.27 t ; 0.87) 15.12 (1.7%) 0.175
GP phone call : NHS 56.00 56 (1.57 t ; 1.75) 0.69 (0.1%) 52 (1.55 t ; 1.59) 0.68 (0.1%) 0.945
GP phone call : patient 0.44 51 (0.87 t ; 0.89) 0.38 (0.0%) 51 (0.95 t ; 1.07) 0.42 (0.0%) 0.529
NHS direct 0.44 23 (0.29 t ; 0.46) 6.52 (0.7%) 11 (0.15 t ; 0.37) 3.37 (0.4%) 0.025
Out-of-hours clinic 22.50 6 (0.14 t ; 0.64) 10.50 (1.2%) 3 (0.07 t ; 0.37) 5.25 (0.6%) 0.087
A&E visit 75.00 20 (0.26 t ; 0.49) 20.54 (2.3%) 7 (0.08 t ; 0.28) 6.32 (0.7%) 0.000
In-patient : infectious disease 79.00 13 (1.32 d; 4.01) 477.84 (52.9%) 14 (1.00 d; 3.25) 362.00 (40.5%) 0.233
Intensive therapy unit 362.00 3 (0.12 d; 0.65) 173.64 (19.2%) 2 (0.25 d; 2.30) 361.75 (40.5%) 0.289
Isolation ward 1447.00 11 (0.93 d; 3.06) 120.90 (13.4%) 8 (0.51 d; 2.09) 66.30 (7.4%) 0.050
Ambulance (to the hospital) 130.00 7 (0.09 t ; 0.29) 19.08 (2.1%) 6 (0.08 t ; 0.27) 16.96 (1.9%) 0.186
Prescribed medicine (charge)# 212.00 18 (0.43 m; 1.01) 4.68 (0.5%) 16 (0.34 m; 0.78) 3.50 (0.4%) 0.259
NHS cost>20 years 18.00 903.12 (100%) 893.18 (100%)
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Table 3 (cont.)
ST (N=124) SE (N=137)
P valueNHS cost category
NHS reference
price (£) n (mean; S.D.)
Cost per
case (£) n (mean; S.D.)
Cost per
case (£)
All age groups, n (mean; S.D.)
n=124 n=137
GP surgery visit 21.40 97 (1.48 t ; 1.28) 31.67 (3.9%) 115 (1.75 t ; 1.52) 37.45 (5.3%) 0.557
GP home visit out of hours 93.73 13 (0.22 t ; 1.02) 20.62 (2.5%) 12 (0.12 t ; 0.38) 11.25 (1.6%) 0.035
Nurse home visit* 56.00 31 (0.36 t ; 0.88) 20.16 (2.5%) 30 (0.30 t ; 0.82) 16.80 (2.4%) 0.343
GP phone call : NHS 0.44 82 (1.48 t ; 1.60) 0.65 (0.1%) 91 (1.55 t ; 1.51) 0.68 (0.1%) 0.971
GP phone call : patient 0.44 68 (0.77 t ; 0.85) 0.34 (0.0%) 85 (0.96 t ; 1.04) 0.42 (0.1%) 0.714
NHS direct 22.50 35 (0.31 t ; 0.46) 6.97 (0.9%) 26 (0.20 t ; 0.40) 4.50 (0.6%) 0.147
Out-of-hours clinic 75.00 12 (0.19 t ; 0.83) 14.25 (1.7%) 4 (0.07 t ; 0.39) 5.25 (0.7%) 0.004
A&E visit 79.00 25 (0.25 t ; 0.56) 19.75 (2.4%) 12 (0.09 t ; 0.29) 7.11 (1.0%) 0.000
In patient : infectious disease 362.00 20 (1.24 d; 3.85) 448.88 (54.9%) 24 (0.88 d; 2.97) 318.56 (45.0%) 0.083
Intensive therapy unit 1447.00 3 (0.08 d; 0.53) 115.76 (14.2%) 1 (0.15 d; 1.79) 217.05 (30.7%) 0.373
Isolation ward 130.00 15 (0.91 d; 3.19) 118.30 (14.5%) 13 (0.57 d; 2.17) 74.01 (10.5%) 0.045
Ambulance (to the hospital) 212.00 9 (0.08 t ; 0.27) 16.96 (2.1%) 7 (0.05 t ; 0.23) 10.60 (1.5%) 0.762
Prescribed medicine (charge)# 18.00 19 (0.30 m; 0.85) 3.31 (0.4%) 20 (0.33 m; 0.96) 3.59 (0.5%) 0.511
NHS cost per case 817.62 (100%) 707.27 (100%)
Overall Salmonella NHS cost/case
(ST+SE=261 cases)
762.44
n, Number of respondents ; mean, all respondents including zeros ; d, days ; t, times ; m, medicines.
* 2004/2005 price.
# We have reduced the charges paid by cases to account for transferences.
P value (0.05) of the t test for the diﬀerence in means for independent-samples or the Mann–Whitney U test if the distribution was non-normal.
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that ST might be more expensive to treat than SE.
These ﬁndings are similar to those found in the IID
study, although no test to detect diﬀerences between
groups was conducted by that investigation. How-
ever, our limited sample size precluded a fully reliable
estimate of the costs.
Table 4. Sensitivity analysis
NHS cost category x50% x20% x10%
Best
estimate 95% CI +10% +20% +50%
ST NHS cost per case
GP surgery visit 15.84 25.34 28.50 31.67 26.75–36.38 34.84 38.00 47.51
GP home visit out of hours 10.31 16.50 18.56 20.62 3.75–37.49 22.68 24.74 30.93
Nurse home visit 10.08 16.13 18.14 20.16 11.76–29.12 22.18 24.19 30.24
GP phone call : NHS 0.33 0.52 0.59 0.65 0.52–0.77 0.72 0.78 0.98
GP phone call : patient 0.17 0.27 0.31 0.34 0.27–0.40 0.37 0.41 0.51
NHS direct 3.49 5.58 6.27 6.97 4.95–9.00 7.67 8.36 10.46
Out-of-hours clinic 7.13 11.40 12.83 14.25 3.75–25.50 15.68 17.10 21.38
A&E visit 9.88 15.80 17.78 19.75 11.85–27.65 21.73 23.70 29.63
In patient : infectious disease 224.44 359.10 403.99 448.88 199.10–695.04 493.77 538.66 673.32
Intensive therapy unit 57.88 92.61 104.18 115.76 101.29–260.46 127.34 138.91 173.64
Isolation ward 59.15 94.64 106.47 118.30 44.20–192.40 130.13 141.96 177.45
Ambulance (to the hospital) 8.48 13.57 15.26 16.96 6.36–27.56 18.66 20.35 25.44
Prescribed medicine (charges) 1.66 2.65 2.98 3.31 1.10–66.00 3.64 3.97 4.97
Total 408.81 654.10 735.86 817.62 — 899.38 981.14 1226.43
SE NHS cost per case
GP surgery visit 18.73 29.96 33.71 37.45 31.89–42.80 41.20 44.94 56.18
GP home visit out of hours 5.63 9.00 10.13 11.25 4.69–16.87 12.38 13.50 16.88
Nurse home visit 8.40 13.44 15.12 16.80 9.52–24.64 18.48 20.16 25.20
GP phone call : NHS 0.34 0.54 0.61 0.68 0.57–0.80 0.75 0.82 1.02
GP phone call : patient 0.21 0.34 0.38 0.42 0.34–0.50 0.46 0.50 0.63
NHS direct 2.25 3.60 4.05 4.50 3.15–6.30 4.95 5.40 6.75
Out-of-hours clinic 2.63 4.20 4.73 5.25 0.75–10.50 5.78 6.30 7.88
A&E visit 3.56 5.69 6.40 7.11 3.16–11.06 7.82 8.53 10.67
In patient : infectious disease 159.28 254.85 286.70 318.56 130.32–492.32 350.42 382.27 477.84
Intensive therapy unit 108.53 173.64 195.35 217.05 0–665.62 238.76 260.46 325.58
Isolation ward 37.01 59.21 66.61 74.01 26.00–120.90 81.41 88.81 111.02
Ambulance (to the hospital) 5.30 8.48 9.54 10.60 2.12–19.08 11.66 12.72 15.90
Prescribed medicine (charge) 1.80 2.87 3.23 3.59 1.10–66.00 3.95 4.31 5.39
Total 353.64 565.82 636.54 707.27 — 778.00 848.72 1060.91
Table 5. Total and mean societal cost for ST and SE (£ sterling,
2007/2008 prices)
ST (N=124) SE (N=137)
Cases and families direct costs 54.93 (4%) 57.52 (6%)
Indirect costs 409.41 (32%) 228.29 (23%)
NHS direct costs 817.62 (64%) 707.27 (71%)
Mean societal costs (per case) 1281.96 (100%) 993.08 (100%)
Number of cases notiﬁed in 2008* 1829 4190
Total family costs (per group) 100 466.97 (A) 241 008.80 (B)
Total indirect costs (per group) 748 810.89 (C) 956 535.10 (D)
Total NHS direct costs (per group) 1 495 426.98 (E) 2 963 461.30 (F)
Total societal costs
(A+B+C+D+E+F)
6 505 710.04
Source : HPA, 2009 [30].
* Provisional data.
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Comparing our ﬁndings with the international es-
timates, we can ﬁnd some similarities. In a 2009 study
in Spain, the cost of a non-speciﬁc Salmonella infec-
tion was estimated to be E2411 (£2150; 2009 mean
exchange rate). However, this investigation included
patients with human immunodeﬁciency virus –
acquired immune deﬁciency syndrome (HIV-AIDS),
neoplasias or immunological cases. No speciﬁc cost
was estimated for ST or SE [32]. Another study in
Spain estimated an overall health system cost of E710
(£633; 2009 mean exchange rate) for gastrointestinal
diseases, including Salmonella. This estimated cost
included hospital admission, visits to A&E, visits to
the GP, and laboratory investigations but no costs to
patients [33].
The estimated overall direct out-of-pocket expenses
of Salmonella cases were relatively stable. For the IID
study, an overall mean cost of £32 was estimated. The
IID study was about 26% higher than our estimates.
Nappies, bleach and washing powder represented a
large element of costs for cases in 1994. In 2007/2008
respondents expended more on transport, nappies
and other items.
The estimated costs in our study are likely to be
underestimated, as we have not included the costs of
cases that were treated at home, investigation costs
and laboratory costs. We did not estimate the cost for
the time lost from education or leisure or the extended
time suﬀering from Salmonella, in spite of the high
estimated number (and proportion) of days when
activities of daily living were aﬀected.
The sensitivity analysis showed that our estimates
were robust and the high variation of the conﬁdence
limits reﬂected the severity of the disease and the small
number of cases in some categories.
This study shows the important impact that
Salmonella infections have on public health costs
and family costs and draws attention to the need to
develop actions aimed at controlling this disease. Our
results will help policy-makers in determining cost-
eﬀective interventions on farms or in abattoirs and
ensure that these costs are commensurate with the
public health impact of salmonellosis.
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